U.S. market Closed. Opens in 1 day 1 hour 34 minutes

NMRD | Nemaura Medical Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-03-312022-03-312021-03-312020-03-312019-03-31
Revenue77.04K503.91KN/AN/AN/A
Cost of Revenue1.55M344.30KN/AN/AN/A
Gross Profit-1.48M159.61KN/AN/AN/A
Operating Expenses8.12M7.73M4.59M4.78M4.48M
Selling, General & Admin5.60M6.17M3.03M2.77M2.18M
Research & Development1.54M1.56M1.55M2.01M2.30M
Other Operating Expenses980.04KN/AN/AN/AN/A
Operating Income-9.60M-7.57M-4.59M-4.78M-4.48M
Other Expenses / Income-4.55M-6.67M-2.01M3.93K23.93K
Before Tax Income-14.14M-14.24M-6.59M-4.77M-4.45M
Income Tax ExpensesN/A-350.26K-335.83K-614.36K23.93K
Net Income-14.14M-13.89M-6.26M-4.16M-4.45M
Interest Expenses6.41M6.67M2.01MN/AN/A
Basic Shares Outstanding24.88M23.38M22.28M20.81M18.09M
Diluted Shares Outstanding24.88M23.38M22.28M20.81M18.09M
EBITDA-7.29M-7.34M-4.49M-4.72M-4.44M
EBITDA Margin-9,458.31%-1,456.74%0.00%0.00%0.00%
EBIT-7.73M-7.57M-4.59M-4.77M-4.43M
EBIT Margin-10,034.83%-1,502.35%0.00%0.00%0.00%
Financial Year End2023-03-312022-03-312021-03-312020-03-312019-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙